{
    "2021-06-06": [
        [
            {
                "time": "",
                "original_text": "对话智飞生物董事长蒋仁生 复盘3000亿市值的资本棋局",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "董事长",
                        "蒋仁生",
                        "资本棋局",
                        "3000亿市值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物蒋仁生：布局未来 借力资本市场加大自主研发投入",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "蒋仁生",
                        "布局未来",
                        "资本市场",
                        "自主研发",
                        "投入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "生物医药行业周报：“三胎”政策发布 辅助生殖为直接受益行业",
                "features": {
                    "keywords": [
                        "生物医药",
                        "行业周报",
                        "三胎政策",
                        "辅助生殖",
                        "受益行业"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "辅助生殖"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}